The human herpesvirus or herpes simplex virus (HHV or HSV) is a neurotropic virus that has two distinct serotypes, human herpesvirus 1 and 2 (HHV-1 and HHV-2). Although both viruses are closely related, they contain sufficient differences to enable type identification ([@B8]). Historically, HHV-1 was considered the main cause of orolabial lesions, and HHV-2 was most commonly associated with genital infections. However, HHV-1 is increasingly being detected in genital lesions, and HHV-2 in orolabial lesions ([@B2]). HHV is highly prevalent in many countries, and HHV infection is a global public health problem ([@B7]). Cell culture is the classic method used in the laboratory to diagnose herpes infection; however, this method is time-consuming and has low sensitivity ([@B5]).

The ability to detect nucleic acid has had a major impact on clinical virology diagnosis ([@B9]). Polymerase chain reaction (PCR) is widely used in HHV research, and among the available PCR methods, quantitative real time PCR (qPCR) has the advantages of speed and quantification. In qPCR, the viral load is measured as the copy number per cell or percentage of total DNA by using a standard curve. A standard curve is generated by qPCR using a dilution series of a DNA template, which is commonly generated from plasmid DNA or DNA oligonucleotides ([@B13]). The advantage of using DNA oligonucleotides is that only the nucleotide sequence needs to be synthesized. For laboratories that do not have enough space or funding for molecular cloning, synthetic curves could be used as an alternative for quantification ([@B13]). Based on these advantages, the aim of this study was to evaluate the potential use of a DNA synthetic oligo as a standard for HHV-1 and HHV-2 quantification.

HPLC-purified oligonucleotides representing an 84-bp sequence of glycoprotein D in HHV-1 and a 91-bp sequence of glycoprotein G in HHV-2 were synthesized ([Table I](#t1){ref-type="table"}). The DNA oligonucleotides were diluted in DNase/RNase-free distilled water to 100 pmol/µL, which is approximately 10^13^ DNA molecules/µL, according to Avogadro's number ([@B13]). These templates were evaluated by qPCR using the primers and probes previously described by [@B14]. Each qPCR contained 12.5 µL of TaqMan® Universal Master Mix (Applied Biosystems, Foster City, CA, USA), 2 µM of each primer, 1.5 µM of probe, and DNase- and RNase-free H~2~O. The cycling conditions were as follows: 95ºC for 10 min (initial denaturation and polymerase activation) followed by 40 cycles of denaturation at 95ºC for 15 s, and annealing and extension at 60ºC for 60 s. In this study, the standard curves were replaced with a ten-fold dilution series (10^1^-10^20^) of Ultramer® oligonucleotides. After determining the dilution range for each synthetic curve, they were assayed along with DNA for use as a standard curve to quantify virus in copies/µL.

TABLE IHuman herpesvirus-1 (HHV-1) and Human herpesvirus-2 (HHV-2) synthetic (oligo) standard curvesSynthetic ultramerSequenceSize (pb)Amount of oligo (nmoles)HHV-15'-TTCGTCTCGTAAAATGGCCCCTCCCGTATGGTTCGTCGGTGTGGTCGGTATGGATGCGTCGATAGTGTCACACGGCCGCTGATA-3'914.4HHV-25'-ATGCTATCTACCCACACACAGACCCACGTACGATCTGGTATCTGGTACTCGAATGTCTCCGCGCATGCAGGGAAGCATTTACGAGAGCGCTGATC-3842.8

Each dilution of the HHV-1 and HHV-2 synthetic curves was compared to the DNA standard curve from virus preparations (quantification range was 10^0^-10^8^ copies/µL). First, the cycle thresholds (CT) of the viral DNA and synthetic oligo curves for both viruses (HHV-1 and HHV-2) were compared. For HHV-1, the CT differences between the DNA and synthetic curves were 0.29-1.28, and for HHV-2, the differences were 0.18-1.1. The amplification efficiency values were E = 97.2% (slope = -3.432, R^2^ = 0.996), with a detection limit of 10^2^ copies/µL for the HHV-1 synthetic curves, and E = 98.4% (slope = -3.285, R^2^ = 0.998), with a detection limit of 10^1^ copies/µL for the HHV-2 synthetic curves (Figure). The standard curve included seven dilution points, and the quantification ranged from 10^2^ to 10^8^ copies/µL for HHV-1 and from 10^1^ to 10^7^ copies/µL for HHV-2.

After evaluating the synthetic standard curves, they were used to quantify HHV-1 and HHV-2 levels in 33 clinical samples by real time qPCR as described above. The 33 samples, which were previously tested by qualitative PCR and with known viral loads, included 15 clinical samples of HHV-1 (two from cell culture, five lesions, five serum samples, and three saliva samples) and 18 clinical samples of HHV-2 (two from cell culture, three lesions, eight serum samples, two saliva samples, and three cervical scrapes). The assay results did not exhibit any discordance by quantitative or qualitative PCR. Furthermore, when DNA samples (each with 20 ng of DNA) from different sources were tested with both standard curves, the absolute quantification did not exceed one log ([Table II](#t2){ref-type="table"}).

TABLE IIComparison of the absolute quantification of human herpesvirus-positive (HHV) samples using synthetic and DNA standard curvesHHV-1HHV-2SamplesDNA curve (copies/uL)Synthetic curve (copies/uL)SamplesDNA curve (copies/uL)Synthetic curve (copies/uL)Lesion 11.3x10^6^2.5x10^6^Cervical scrape 17.8x10^5^6.7x10^5^Lesion 21.5x10^4^2.9x10^4^Cervical scrape 21.9x10^4^1.0x10^4^Lesion 35.7x 10^6^7.1x10^6^Cervical scrape 37.9 x 10^4^6.8x10^4^Serum 13.2x10^2^4.3x10^2^Serum 12.1.x10^1^5.3x10^1^Serum 21.0 x10^0^1.9x10^0^Serum 22.9x10^2^3.5x10^2^Serum 34.6x10^1^3.8x10^1^Serum 35.9x10^0^6.7x10^0^Serum 42.7x10^1^1,9x10^1^Serum 46.8x10^2^7.6x10^2^Serum 52.7x10^2^1.8x10^2^Serum 51.7x10^1^4.7x10^1^Cell culture 18.9x10^7^9.5x10^7^Serum 65.2 x10^1^8.3x10^1^Cell culture 26.6x10^7^7.8x10^7^Serum 73.4x10^2^4.3x10^2^Saliva 17.4x10^3^8.7x10^3^Serum 86.6x10^2^7.4x10^2^Saliva 23.2x10^3^4.4x10^3^Cell culture 19.4x10^6^7.5x10^6^Saliva 35.9x10^3^7.1x10^3^Cell culture 23.2x10^7^2.4x10^7^\-\--Saliva 12.9x10^2^3.8x10^2^\-\--Saliva 29.1x10^2^9.8x10^2^\-\--Lesion 17.5x10^5^6.3x10^5^\-\--Lesion 23.3x10^6^1.5x10^6^\-\--Lesion 32.2x10^5^1.0x10^5^

Other authors have described improvements in the sensitivity and specificity of HHV diagnosis, and they were able to detect shedding episodes in the absence of clinical lesions ([@B1], da [@B6], [@B3], [@B10], [@B11]) and diagnose clinical specimens that had a viral load lower than lesion swabs, such as cerebral fluid, plasma ([@B12]), saliva, and cervical scrapes, as was demonstrated in the present study.

The use of this synthetic curve is currently limited to scientific research laboratories. However, previous studies have shown that oligonucleotides are good alternatives for quantification methods ([@B4], [@B13]. This study demonstrated that synthetic curves could be used as alternative standard curves for HHV diagnosis, since they showed similar results when compared to viral DNA curves.

Amplification plots on a log scale and standard curves. (A) Human herpesvirus-1 (HHV-1); (B) human herpesvirus-2 (HHV-2).
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